Mega Lifesciences PCL
Mega Lifesciences's GHG Emissions Data Preview
In 2023, Mega Lifesciences completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
Mega Lifesciences has also provided a category-level breakdown for 1 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Mega Lifesciences's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Mega Lifesciences amounted to 8,561.46 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Mega Lifesciences increased by 1,280.72%, suggesting that the company faced challenges in reducing its emissions from its core operations.
Mega Lifesciences's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Mega Lifesciences's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Mega Lifesciences were 1,808.57 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Mega Lifesciences reduced its Scope 1 emissions over time?
Since 2018, Mega Lifesciences's Scope 1 emissions have increased by 670.26%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), Mega Lifesciences's Scope 1 emissions increased by 1,389.27%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
What are Mega Lifesciences's Scope 2 emissions?
In 2023, Mega Lifesciences reported Scope 2 greenhouse gas (GHG) emissions of 6,752.89 tCOâ‚‚e without specifying the calculation method.
Has Mega Lifesciences reduced its Scope 2 emissions over time?
Since 2018, Mega Lifesciences's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 857.68%, reflecting a rising long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), Mega Lifesciences's Scope 2 emissions (Unspecified Calculation Method) rose by 1,254.29% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy
What methodology does Mega Lifesciences use for Scope 2 reporting?
In 2023, Mega Lifesciences reported its Scope 2 emissions using an unspecified methodology.
Mega Lifesciences's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Mega Lifesciences's Value Chain Emissions
In 2023, Mega Lifesciences reported 6,752.89 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2023 disclosure of Mega Lifesciences includes a breakdown across 1 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2022, demonstrating consistent Scope 3 emissions reporting coverage year over year.
Mega Lifesciences's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Mega Lifesciences's Scope 3 emissions?
In 2023, Mega Lifesciences reported total Scope 3 emissions of 6,752.89 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment.
Has Mega Lifesciences reduced its Scope 3 emissions over time?
Since 2018, Mega Lifesciences's Scope 3 emissions have increased by 857.68%, reflecting a rising long-term trend in Scope 3 emissions over time.
Compared to the previous year (2022), Mega Lifesciences's Scope 3 emissions increased by 1,254.29%, suggesting that the company faced challenges in reducing emissions across its value chain.
What categories of Scope 3 emissions does Mega Lifesciences disclose?
In 2023, Mega Lifesciences reported emissions for 1 out of the 15 Scope 3 categories defined by the GHG Protocol.
The limited disclosure restricts visibility into specific emission sources across the company's value chain.
What are the main sources of Mega Lifesciences's Scope 3 emissions?
In 2023, the largest contributors to Mega Lifesciences's Scope 3 emissions were:
- Fuel- and Energy-Related Services (Cat. 3): 439.53 tCOâ‚‚e (100%)
Mega Lifesciences's Scope 3 Emissions by Categories
Insights into Mega Lifesciences's Total Carbon Footprint
In 2023, Mega Lifesciences reported a total carbon footprint of 15,314.35 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 1,268.94% increase compared to 2022, suggesting a rise in emissions across its operations or value chain.
The largest contributor to Mega Lifesciences's total carbon footprint was Scope 2 emissions, accounting for 44.1% of the company's total carbon footprint, followed by Scope 3 emissions at 44.1%.